Rockwell Medical (RMTI) Revenue & Revenue Breakdown
Rockwell Medical Revenue Highlights
Latest Revenue (Y)
$83.61M
Latest Revenue (Q)
$22.68M
Main Segment (Y)
Concentrate Products
Main Geography (Y)
UNITED STATES
Rockwell Medical Revenue by Period
Rockwell Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $83.61M | 14.84% |
| 2022-12-31 | $72.81M | 17.57% |
| 2021-12-31 | $61.93M | -0.43% |
| 2020-12-31 | $62.20M | 1.46% |
| 2019-12-31 | $61.30M | -3.29% |
| 2018-12-31 | $63.39M | 10.63% |
| 2017-12-31 | $57.30M | 7.54% |
| 2016-12-31 | $53.28M | -3.73% |
| 2015-12-31 | $55.35M | 2.14% |
| 2014-12-31 | $54.19M | 3.45% |
| 2013-12-31 | $52.38M | 5.09% |
| 2012-12-31 | $49.84M | 1.79% |
| 2011-12-31 | $48.97M | -17.78% |
| 2010-12-31 | $59.55M | 8.82% |
| 2009-12-31 | $54.73M | 5.93% |
| 2008-12-31 | $51.67M | 20.03% |
| 2007-12-31 | $43.05M | 50.30% |
| 2006-12-31 | $28.64M | 3.41% |
| 2005-12-31 | $27.69M | 54.33% |
| 2004-12-31 | $17.94M | 19.87% |
| 2003-12-31 | $14.97M | 30.22% |
| 2002-12-31 | $11.50M | 27.51% |
| 2001-12-31 | $9.02M | 20.90% |
| 2000-12-31 | $7.46M | 11.30% |
| 1999-12-31 | $6.70M | 26.42% |
| 1998-12-31 | $5.30M | 60.61% |
| 1997-12-31 | $3.30M | - |
Rockwell Medical generated $83.61M in revenue during NA 2023, up 14.84% compared to the previous quarter, and up 131.90% compared to the same period a year ago.
Rockwell Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $22.68M | 2.64% |
| 2023-12-31 | $22.09M | -7.06% |
| 2023-09-30 | $23.77M | 31.48% |
| 2023-06-30 | $18.08M | -8.07% |
| 2023-03-31 | $19.67M | 1.84% |
| 2022-12-31 | $19.31M | 3.33% |
| 2022-09-30 | $18.69M | 0.05% |
| 2022-06-30 | $18.68M | 15.86% |
| 2022-03-31 | $16.12M | 5.17% |
| 2021-12-31 | $15.33M | -4.10% |
| 2021-09-30 | $15.99M | 5.62% |
| 2021-06-30 | $15.14M | -2.17% |
| 2021-03-31 | $15.47M | 2.04% |
| 2020-12-31 | $15.16M | -0.76% |
| 2020-09-30 | $15.28M | -3.88% |
| 2020-06-30 | $15.90M | 0.25% |
| 2020-03-31 | $15.86M | 2.36% |
| 2019-12-31 | $15.49M | 0.54% |
| 2019-09-30 | $15.41M | 3.78% |
| 2019-06-30 | $14.85M | -4.59% |
| 2019-03-31 | $15.56M | -7.68% |
| 2018-12-31 | $16.85M | 1.09% |
| 2018-09-30 | $16.67M | 11.80% |
| 2018-06-30 | $14.91M | -0.24% |
| 2018-03-31 | $14.95M | 0.75% |
| 2017-12-31 | $14.84M | 1.44% |
| 2017-09-30 | $14.63M | 10.45% |
| 2017-06-30 | $13.24M | -9.25% |
| 2017-03-31 | $14.59M | 8.98% |
| 2016-12-31 | $13.39M | 4.49% |
| 2016-09-30 | $12.81M | -4.74% |
| 2016-06-30 | $13.45M | -1.28% |
| 2016-03-31 | $13.63M | -3.58% |
| 2015-12-31 | $14.13M | -1.71% |
| 2015-09-30 | $14.38M | 10.98% |
| 2015-06-30 | $12.96M | -6.69% |
| 2015-03-31 | $13.88M | -3.90% |
| 2014-12-31 | $14.45M | 5.12% |
| 2014-09-30 | $13.74M | 5.45% |
| 2014-06-30 | $13.03M | 0.54% |
| 2014-03-31 | $12.96M | -7.17% |
| 2013-12-31 | $13.96M | 6.65% |
| 2013-09-30 | $13.09M | 0.85% |
| 2013-06-30 | $12.98M | 5.25% |
| 2013-03-31 | $12.34M | -5.10% |
| 2012-12-31 | $13.00M | 2.45% |
| 2012-09-30 | $12.69M | 4.66% |
| 2012-06-30 | $12.12M | 0.80% |
| 2012-03-31 | $12.03M | 1.11% |
| 2011-12-31 | $11.90M | -0.66% |
| 2011-09-30 | $11.98M | 1.47% |
| 2011-06-30 | $11.80M | -11.20% |
| 2011-03-31 | $13.29M | -7.20% |
| 2010-12-31 | $14.32M | -2.87% |
| 2010-09-30 | $14.75M | -4.91% |
| 2010-06-30 | $15.51M | 3.52% |
| 2010-03-31 | $14.98M | 1.48% |
| 2009-12-31 | $14.76M | 4.26% |
| 2009-09-30 | $14.16M | 8.80% |
| 2009-06-30 | $13.01M | 1.69% |
| 2009-03-31 | $12.80M | -5.47% |
| 2008-12-31 | $13.54M | 0.03% |
| 2008-09-30 | $13.53M | 11.10% |
| 2008-06-30 | $12.18M | -1.85% |
| 2008-03-31 | $12.41M | 3.88% |
| 2007-12-31 | $11.95M | - |
Rockwell Medical generated $22.68M in revenue during Q1 2024, up 2.64% compared to the previous quarter, and up 117.41% compared to the same period a year ago.
Rockwell Medical Revenue Breakdown
Rockwell Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Drug Revenue | $2.34M | - | - | - | - |
| Concentrate Products | $81.27M | - | - | - | - |
| Upfront Fee | - | $2.50M | $1.90M | $2.00M | - |
| Product | - | - | - | - | $59.00M |
| License | - | - | - | - | $2.30M |
Rockwell Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Concentrate Products (97.20%), and Drug Revenue (2.80%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Dec 18 |
|---|---|---|---|---|
| Concentrate Products | $22.66M | $59.70M | $21.57M | $16.79M |
| Drug Revenue | $11.00K | $141.00K | $2.20M | $68.00K |
Rockwell Medical's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Concentrate Products (99.95%), and Drug Revenue (0.05%).
Rockwell Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Non-US | $9.27M | $598.00K | $241.00K | $226.00K | $273.00K |
| UNITED STATES | $74.34M | $561.00K | $835.00K | $910.00K | $272.00K |
Rockwell Medical's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (88.91%), and Non-US (11.09%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $20.93M | $54.60M | $19.74M | - | - | - | $193.00K | $209.00K | $159.00K | $179.00K | $217.00K | $215.00K | $225.00K | $301.00K | $228.00K | $182.00K | $199.00K | $13.94M | - | - |
| Non-US | $1.74M | $5.11M | $4.03M | $65.00K | $65.00K | $133.00K | $65.00K | $338.00K | $62.00K | $62.00K | $62.00K | $58.00K | $58.00K | $59.00K | $56.00K | $56.00K | $56.00K | $1.33M | - | - |
| U | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $13.85M | $13.32M |
| Non Us | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.46M | $1.51M |
Rockwell Medical's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (92.32%), and Non-US (7.68%).
Rockwell Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| ITCI | Intra-Cellular Therapies | $462.18M | $175.38M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| KMDA | Kamada | $144.76M | $37.40M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| ACOR | Acorda Therapeutics | $102.42M | $20.29M |
| RMTI | Rockwell Medical | $83.61M | $22.68M |
| AQST | Aquestive Therapeutics | $50.58M | $20.10M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.85M |
| BFRI | Biofrontera | $34.01M | $7.83M |
| AGRX | Agile Therapeutics | $19.59M | $5.58M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
| EVOK | Evoke Pharma | $5.18M | $1.74M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| ACRX | Talphera | $651.00K | $117.00K |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| IXHL | Incannex Healthcare | - | - |
| HUGE | FSD Pharma | - | - |
| RGC | Regencell Bioscience | - | - |
RMTI Revenue FAQ
What is Rockwell Medical’s yearly revenue?
Rockwell Medical's yearly revenue for 2023 was $83.61M, representing an increase of 14.84% compared to 2022. The company's yearly revenue for 2022 was $72.81M, representing an increase of 17.57% compared to 2021. RMTI's yearly revenue for 2021 was $61.93M, representing a decrease of -0.43% compared to 2020.
What is Rockwell Medical’s quarterly revenue?
Rockwell Medical's quarterly revenue for Q1 2024 was $22.68M, a 2.64% increase from the previous quarter (Q4 2023), and a 15.29% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $22.09M, a -7.06% decrease from the previous quarter (Q3 2023), and a 14.39% increase year-over-year (Q4 2022). RMTI's quarterly revenue for Q3 2023 was $23.77M, a 31.48% increase from the previous quarter (Q2 2023), and a 27.18% increase year-over-year (Q3 2022).
What is Rockwell Medical’s revenue growth rate?
Rockwell Medical's revenue growth rate for the last 3 years (2021-2023) was 35.01%, and for the last 5 years (2019-2023) was 36.39%.
What are Rockwell Medical’s revenue streams?
Rockwell Medical's revenue streams in c 23 are Drug Revenue, and Concentrate Products. Drug Revenue generated $2.34M in revenue, accounting 2.80% of the company's total revenue Concentrate Products generated $81.27M in revenue, accounting 97.20% of the company's total revenue
What is Rockwell Medical’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Rockwell Medical was Concentrate Products. This segment made a revenue of $81.27M, representing 97.20% of the company's total revenue.